Endometrial Adenosquamous Carcinoma
NCI Definition: A rare endometrial carcinoma characterized by the presence of both malignant glandular and malignant squamous cellular components. 
Endometrial adenosquamous carcinomas most frequently harbor alterations in PIK3CA, TP53, PTEN, VHL, and STK11 .
PIK3CA Mutation, TP53 c.217-c.1178 Missense, TP53 Mutation, TP53 Missense, and TP53 Exon 8 Mutation are the most common alterations in endometrial adenosquamous carcinoma .
There is 1 clinical trial for endometrial adenosquamous carcinoma, of which 1 is open and 0 are completed or closed. Of the trial that contains endometrial adenosquamous carcinoma as an inclusion criterion, 1 is phase 2 (1 open).
Onc201 is the most common intervention in endometrial adenosquamous carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.